Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia
- PMID: 18056245
- PMCID: PMC3062255
- DOI: 10.1176/appi.ajp.2007.05111903
Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia
Abstract
Objective: Factors underlying progressive brain volume changes in schizophrenia remain poorly understood. The authors investigated whether a gene polymorphism influencing neuroplasticity may contribute to longitudinal brain volume alterations.
Method: High-resolution magnetic resonance (MR) images of the whole brain were obtained for 119 patients with recent-onset schizophrenia spectrum disorders. Changes in brain volumes over an average of 3 years were compared between brain-derived neurotrophic factor (BDNF) val66met genotype groupings. Exploratory analyses were conducted to examine relationships between antipsychotic treatment and brain volume changes as well as the effects of BDNF genotype on changes in cognition and symptoms.
Results: Significant genotype effects were observed on within-subject changes in volumes of frontal lobe gray matter, lateral ventricles, and sulcal CSF. Met allele carriers had significantly greater reductions in frontal gray matter volume, with reciprocal volume increases in the lateral ventricles and sulcal (especially frontal and temporal) CSF than Val homozygous patients. Independent of BDNF genotype, more antipsychotic exposure between MRI scans correlated with greater volume reductions in frontal gray matter, particularly among patients who were initially treatment naive. There were no statistically significant genotype effects on within-subject changes in cognition or symptoms.
Conclusions: BDNF(Met) variant may be one of several factors affecting progressive brain volume changes in schizophrenia.
Figures
Similar articles
-
Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.Arch Gen Psychiatry. 2006 Jul;63(7):731-40. doi: 10.1001/archpsyc.63.7.731. Arch Gen Psychiatry. 2006. PMID: 16818862 Free PMC article.
-
Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.Hippocampus. 2010 Sep;20(9):1010-7. doi: 10.1002/hipo.20699. Hippocampus. 2010. PMID: 19714565
-
Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.Neurosci Lett. 2006 Jun 19;401(1-2):1-5. doi: 10.1016/j.neulet.2006.02.054. Epub 2006 Mar 14. Neurosci Lett. 2006. PMID: 16533563
-
BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.Schizophr Res. 2014 Feb;152(2-3):365-72. doi: 10.1016/j.schres.2013.12.011. Epub 2014 Jan 7. Schizophr Res. 2014. PMID: 24411528 Free PMC article.
-
A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum Levels.Neuropsychobiology. 2021;80(5):411-424. doi: 10.1159/000514126. Epub 2021 Mar 11. Neuropsychobiology. 2021. PMID: 33706323 Free PMC article. Review.
Cited by
-
Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-naïve patients with schizophrenia.J Mol Neurosci. 2012 Jul;47(3):505-10. doi: 10.1007/s12031-012-9750-4. Epub 2012 Apr 3. J Mol Neurosci. 2012. PMID: 22477643
-
Fully automated analysis using BRAINS: AutoWorkup.Neuroimage. 2011 Jan 1;54(1):328-36. doi: 10.1016/j.neuroimage.2010.06.047. Epub 2010 Jun 25. Neuroimage. 2011. PMID: 20600977 Free PMC article.
-
Brain-derived neurotrophic factor and schizophrenia.Psychiatr Genet. 2019 Oct;29(5):200-210. doi: 10.1097/YPG.0000000000000237. Psychiatr Genet. 2019. PMID: 31465000 Free PMC article. Review.
-
Impact of brain-derived neurotrophic factor genetic polymorphism on cognition: A systematic review.Brain Behav. 2018 Jul;8(7):e01009. doi: 10.1002/brb3.1009. Epub 2018 Jun 1. Brain Behav. 2018. PMID: 29858545 Free PMC article.
-
Genetic contributions to age-related decline in executive function: a 10-year longitudinal study of COMT and BDNF polymorphisms.Front Hum Neurosci. 2008 Sep 23;2:11. doi: 10.3389/neuro.09.011.2008. eCollection 2008. Front Hum Neurosci. 2008. PMID: 18958211 Free PMC article.
References
-
- Schulz SC, Koller MM, Kishore PR, Hamer RM, Gehl JJ, Friedel RO. Ventricular enlargement in teenage patients with schizophrenia spectrum disorder. Am J Psychiatry. 1983;140(12):1592–5. - PubMed
-
- DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 1997;74(3):129–40. - PubMed
-
- Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, Gur RC. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry. 1998;55(2):145–52. - PubMed
-
- Lieberman J, Chakos M, Wu H, Alvir J, Hoffman E, Robinson D, Bilder R. Longitudinal study of brain morphology in first episode schizophrenia. Biol Psychiatry. 2001;49(6):487–99. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous